MERCURY LABORATORIES LIMITEDMM

MERCURY LABORATORIES LIMITED

809.15INRD
−10.35−1.26%
At close at 11:09 GMT
INR
No trades
See on Supercharts

MERCURYLAB fundamentals

Key facts

Market capitalization‪983.40 M‬INR
Founded1962
CEORajendra Ramanlal Shah
About

Mercury Laboratories Ltd. engages in the production and sale of pharmaceuticals and its related products. It offers products for pediatrics, obstetrics, gynecology, surgery, and general sectors. The company was founded in 1962 and is headquartered in Vadodara, India.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪983.40 M‬‬
Price to earning ratio (P/E)
24.93x
Price to sales ratio (P/S)
1.37x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
24.93x
Price to sales ratio (P/S)
1.37x
Valuation ratios
‪0.00‬
‪0.50‬
‪1.00‬
‪1.50‬
‪2.00‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪8.00‬
‪16.00‬
‪24.00‬
‪32.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪2.0%‬
‪4.5%‬
‪7.0%‬
‪9.5%‬
‪12.0%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Bulk Drug Intermediates and Related Products
By country
Period: 2023
India
Asia
America
Europe
Africa

Dividends

Dividend yield, history and sustainability

Dividend summary
10.65%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.43%
Last payment
3.50
Last ex-date
Sep 20, 2024
Dividend history
‪0.40%‬
‪0.49%‬
‪0.58%‬
‪0.67%‬
‪0.76%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.90‬
‪1.80‬
‪2.70‬
‪3.60‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
‪‪60.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities